fingolimod hydrochloride has been researched along with Lymphedema in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cuzzone, DA; GarcĂa Nores, GD; Gardenier, JC; Hespe, GE; Huang, JJ; Kataru, RP; Ly, CL; Mehrara, BJ; Nitti, MD; Rehal, S; Savetsky, IL; Torrisi, JS; Yu, JZ | 1 |
1 other study(ies) available for fingolimod hydrochloride and Lymphedema
Article | Year |
---|---|
CD4
Topics: Adoptive Transfer; Animals; CD4 Antigens; CD4-Positive T-Lymphocytes; Cell Differentiation; Dendritic Cells; Disease Models, Animal; Female; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Lymph Nodes; Lymphangiogenesis; Lymphatic Vessels; Lymphedema; Lymphocyte Activation; Mice; Mice, Inbred C57BL; Mice, Knockout; Receptors, Lysosphingolipid; Skin | 2018 |